Takeda offloads URL generics business to Caraco for $65m
This article was originally published in Scrip
Executive Summary
In a move expected since it completed the acquisition of the private US firm in June, Takeda is divesting the generics business of URL Pharma, with the Caraco Pharmaceutical Laboratories subsidiary of India's Sun Pharmaceutical Industries emerging as the buyer.